Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice of chemotherapy in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL) Meeting Abstract
| Authors: | Phillips, A. A.; Fields, P.; Hermine, O.; Taylor, G.; DelloukIna, M. L.; Horwitz, S. M.; Ramos, J. C.; Menlane, J. C.; Barta, S. K.; Or, K. M.; Kurman, M. R.; Saunders, A.; Grebennik, D. O.; Conlon, K. |
| Abstract Title: | Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice of chemotherapy in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL) |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613202224 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.tps8622 |
| Notes: | Meeting Abstract: TPS8622 -- Source: Wos |
